Sept 10 (Reuters) - Discovery Laboratories Inc:
* Labs and FDA to meet on September 29, 2009 to discuss potential path for
surfaxin approval
* Says also plans to review quality improvement efforts, further refine
biological activity test
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Labs and FDA to meet on September 29, 2009 to discuss potential path for
surfaxin approval
* Says also plans to review quality improvement efforts, further refine
biological activity test
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2009 AFX News
